Alberts, Ian; Sachpekidis, Christos; Fech, Viktor; Rominger, Axel; Afshar-Oromieh, Ali (2020). PSMA-negative prostate cancer and the continued value of choline-PET/CT. Nuklearmedizin, 59(1), pp. 33-34. Thieme 10.1055/a-1044-1855
![[img]](https://boris.unibe.ch/style/images/fileicons/text.png) |
Text
Alberts_PSMA-negative prostate cancer and the continued value of choline PETCT.pdf - Published Version Restricted to registered users only Available under License Publisher holds Copyright. Download (1MB) | Request a copy |
Owing to their superior uptake and higher detection rate, PSMA-labelled radioligands have largely replaced choline in routine clinical imaging of recurrent prostate cancer (PCa). Nevertheless, even at high PSA values, a small number of patients can present with PSMA negative prostate cancer (PC) lesions. For such patients choline PET continues to play an important role.
Item Type: |
Journal Article (Further Contribution) |
|---|---|
Division/Institute: |
04 Faculty of Medicine > Department of Radiology, Neuroradiology and Nuclear Medicine (DRNN) > Clinic of Nuclear Medicine |
UniBE Contributor: |
Alberts, Ian Leigh, Sachpekidis, Christos, Fech, Viktor, Rominger, Axel Oliver, Afshar Oromieh, Ali |
Subjects: |
600 Technology > 610 Medicine & health |
ISSN: |
0029-5566 |
Publisher: |
Thieme |
Language: |
Multilingual |
Submitter: |
Sabine Lanz |
Date Deposited: |
18 Dec 2019 10:28 |
Last Modified: |
05 Dec 2022 15:34 |
Publisher DOI: |
10.1055/a-1044-1855 |
PubMed ID: |
31766065 |
BORIS DOI: |
10.7892/boris.136797 |
URI: |
https://boris.unibe.ch/id/eprint/136797 |
Actions (login required)
 |
Edit item |